Baxalta baxalta.com


Public list: BIO 2016 (619) Pharma Startups (4743) Cancer Therapeutics (1148) Rare Diseases (230)

Baxalta (NYSE: BXLT) is a global biopharmaceutical leader developing, manufacturing and commercializing therapies for orphan diseases and underserved conditions in hematology, oncology and immunology. Driven by passion to make a meaningful impact on patients' lives, Baxalta's broad and diverse pipeline includes biologics with novel mechanisms and advanced technology platforms such as gene therapy. The Company's therapies are available in more than 100 countries and it has advanced biological man...Show all

Baxalta (NYSE: BXLT) is a global biopharmaceutical leader developing, manufacturing and commercializing therapies for orphan diseases and underserved conditions in hematology, oncology and immunology. Driven by passion to make a meaningful impact on ...Show all

Company (Acquired)

Phone: 224-948-2000

Fax:

1200 Lakeside Drive

 Bannockburn, 60015
 Illinois, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Baxalta $0M Jan 11, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Baxalta Jobs

jobs by Indeed job search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Medium for the protein-free and serum-free cultivation of cells Aug 12, 2016 May 29, 2018 Patent
Recombinant cell clones having increased stability and methods of making and using the same Jul 06, 2016 May 22, 2018 Patent
Oxmif as a diagnostic marker Oct 04, 2012 May 01, 2018 Patent
Stabilized liquid and lyophilized adamts13 formulations Jan 06, 2017 Apr 10, 2018 Patent
Recombinant cell clones having increased stability and methods of making and using the same Dec 11, 2014 Mar 06, 2018 Patent
See all 154 patents